Advertisement

Topics

Synthace Company Profile

22:22 EST 20th February 2019 | BioPortfolio

Based in London, Synthace is developing Antha, a language and software platform specifically for biology that lets researchers aim higher and achieve better results, faster. Antha is designed to make reproducible and scalable workflows that can be readily edited and shared, and easily automated on labs’ existing equipment. In 2016, the World Economic Forum included Synthace in its selection of the world’s 30 most promising Technology Pioneers that are helping shape the Fourth Industrial Revolution – a technological revolution that will fundamentally alter the way we live, work and relate to one another. For more information, visit: www.synthace.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Synthace Launches Ground-Breaking New Whitepaper: Computer-Aided Biology: Delivering Biotechnology in the 21st Century

Comprehensive report heralds the beginning of Computer Aided Biology (CAB) October 01, 2018 09:00 AM Eastern Daylight Time – LONDON–(BUSINESS WIRE)–Synthace Ltd., the company behind ...

Digest #253 – $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!

  Your guide to what’s new in synthetic biology Hi all, It’s been a phenomenal week for the synthetic biology industry with $1.2B flowing into the industry from a couple of big IPOs and s...

Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding

Funding will be used to further expand product capabilities and fuel company growth Industry-leader is bringing software abstraction and automation to ...

Series B Boosts British Biotech’s Cell Therapy Automation With €22.6M

The UK company Synthace has raised €22.6M to develop its software platform to automate and improve the manufacturing process in gene and cell therapy. The round, led by Hong Kong-based investor Hori...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Synthace

Based in London, Synthace is developing Antha, a language and software platform specifically for biology that lets researchers aim higher and achieve better results, faster. Antha...

More Information about "Synthace" on BioPortfolio

We have published hundreds of Synthace news stories on BioPortfolio along with dozens of Synthace Clinical Trials and PubMed Articles about Synthace for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synthace Companies in our database. You can also find out about relevant Synthace Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record